This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
The Chinese Wireless Communications Industry in 2012 and Beyond: An Industry Note - Teaching Note
Burgelman, R; Gang, Zheng,, Yajuan, WangTeaching Note SGSB-SM227TN-EStrategyThis industry note provides an extensive overview of the wireless communications industry in China at the end of 2012. At the time China had over 1.1 billion mobile subscribers, and the country was predicted to have 500 million smartphones in use by the end of 2013. The note discusses the industry’s value chain (carriers, device manufactures, component providers, content and applications providers, and telecom equipment providers), and the role o...Starting at €0.00
-
Scholtes Waterservices
Vanessa M. Strike; Lisa BarendseCase IVEY-9B12M067-EEntrepreneurship, StrategyHIGHLY COMMENDED CASE - Family Business Runner-up, 2012 European Foundation for Management Development (EFMD) Case Writing Competition. Scholtes Waterservices was a second-generation family firm in the Netherlands that specialized in installing and selling water pipes, primarily for the horticultural industry. In 2008, Rijk Scholtes Jr. and his brother, Ben, took over management of the firm from their father and gradually assumed ownership throug...Starting at €8.20
-
Easepal: Transforming a Chinese OEM Supplier
Chuang Chen; Ning SuCase IVEY-9B16M005-EEntrepreneurship, StrategyAs one of the world’s largest OEM suppliers of electric massaging equipment, China’s Easepal has faced increasing challenges in its traditional OEM business over the course of two decades. Since the company’s inception in the 1990s, its founder has always had the ambitious goal of becoming more than just a supplier in the global electric massager market. Easepal’s mature research and development and manufacturing capabilities have the potential t...Starting at €8.20
-
Fengshou Crab Manor
Yan Gong; Liman Zhao; Liang DongCase IVEY-9B16M063-EEntrepreneurship, StrategySince its founding in 2002, Fengshou Crab Manor had become one of the top brands in China’s mitten crab sector by using a distinctive gift voucher model. The company had attracted over 100,000 loyal customers from companies and non-profit institutions in Beijing and Shanghai. At the beginning of 2013, however, the government’s Central Committee unveiled an eight-point code of conduct to reduce bureaucracy and boost ties with the public, which adv...Starting at €8.20
-
CPT: The Constant Hunt for Entrepreneurial Opportunities
S. Ramakrishna Velamuri; Liman ZhaoCase IVEY-9B16M067-EEntrepreneurship, StrategyAfter continuous business growth and taking advantage of new business opportunities, China Precision Technology Group transformed from a small producer of coils for television tuners to an enterprise with five different business sectors: consumer electronics, automobile parts, optical, health care, and stamping equipment. In 2014, on the company’s 24th anniversary, the company’s founder and chief executive officer was evaluating the achievements ...Starting at €8.20
-
Testin: Partnering with Multinational Corporations
Shameen Prashantham; Liman ZhaoCase IVEY-9B17M127-EEntrepreneurship, StrategyBy 2017, Beijing Testin Information Technology Co., Ltd. (Testin), had forged partnerships with multiple large multinational companies (e.g., Microsoft, IBM, ARM, Intel). Since it was founded in 2011, Testin had served over 800,000 application developers by conducting more than 150 million quality and security tests on over 2.5 million mobile applications. It had received several rounds of financing totaling over $80 million. Many Chinese Interne...Starting at €8.20
-
Shanghai Pharmaceuticals: Seeking A Prescription For Digital Transformation
Ming Dong; Ning SuCase IVEY-9B18M001-EEntrepreneurship, StrategyBy 2015, China had one of the world’s largest and most complex healthcare industries. This industry had been undergoing unprecedented change in diverse areas, from policies to technologies. Shanghai Pharmaceuticals, China’s second-largest pharmaceutical company, spanned the entire pharmaceutical value chain, from product research and development to sales. The company’s core competency was in drug distribution, which generated 70 per cent of the f...Starting at €8.20
-
Compassion Web
Wee Yong YeoCase IVEY-9B12M039-EEntrepreneurship, Finance, StrategyThis case is about an ambitious “technopreneur” with ideas that were at the forefront of technology, such as in enterprise resource planning (ERP) systems. Compassion Web had been successful initially, then swamped with challenges, and the original business model needed major changes in order to work in the fast-changing environment. At the same time, the company was facing a lawsuit with a major client, which could threaten its survival. To make...Starting at €8.20
-
I-Star: Expanding in North America
William Wei; Xiaohua Yang; Roger Chen; Kimberley Howard; Stanley KwongCase IVEY-9B12M041-EInformation Technologies, Marketing, StrategyThe president of I-Star America, Inc. and vice-president of I-Star Corporation reflected on the success of I-Star in the Chinese and Japanese IT markets and the challenges of increasing market share in North America, one of the largest markets in the world. I-Star was expected to grow about 30 per cent in the next few years, and the president considered whether the strategy used in Japan could be applied to North America.Many Chinese firms that e...Starting at €8.20
-
Olam: Accounting for Biological Assets
Yew Kee Ho; Chee Khiang Teo; Kheng Hoe SitohCase IVEY-9B15A042-EAccounting and Control, StrategyIn 2012, an equity research firm based in California accused Singapore-based Olam International Limited (Olam) of engaging in potentially misleading and dangerous accounting practices. The firm — Muddy Waters Research — further stated that Olam was on the verge of bankruptcy. The primary complaint made against Olam by Muddy Waters was that Olam allegedly made aggressive use of “non-cash accounting gains,” particularly when reporting on Olam’s bio...Starting at €8.20